Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 9 of 9« First...56789

Sangamo, Pfizer to develop gene therapy for ALS

Sangamo Therapeutics Inc. and Pfizer Inc. are partnering to develop a gene therapy to treat a disease that affects nerve cells in the brain and the spinal cord.

Read More »

Novartis breast cancer therapy gets FDA breakthrough designation

Novartis’ Kisqali (ribociclib) won U.S. Food and Drug Administration breakthrough therapy designation for treating some breast cancer patients.

Read More »

Drugmakers raise 2018 U.S. prices

2018 opened with elevated U.S. prices on dozens of medicines, but early data showed the increases generally remained within a 10 percent self-imposed limit.

Read More »

FDA issues recall on J&J heart device

The U.S. Food and Drug Administration issued a recall of a heart device made by a unit of Johnson & Johnson due to a faulty valve.

Read More »

Ackman, Valeant Pay $290M to End Allergan Insider Trading Lawsuit

Pershing Square, a hedge fund run by activist investor William Ackman, and Valeant decided to settle an insider trading lawsuit with Allergan and pay $290 million.

Read More »

Immune cells linked to very early spread of breast cancer

Normal immune cells that live near milk ducts in healthy breast tissue may play a key role in helping early breast cancer cells leave the breast for other parts of the body, researchers say.

Read More »

Starting new COPD inhaler tied to heart attack risk

People with chronic obstructive pulmonary disease (COPD) who use long-acting inhaled bronchodilators may have an increased risk of heart attacks and strokes right after they start taking these medicines, a Taiwanese study suggests.

Read More »

FDA Accepts Supplemental Biologics License Application and Grants Priority Review for Adcetris in Frontline Advanced Hodgkin Lymphoma

Normal immune cells that live near milk ducts in healthy breast tissue may play a key role in helping early breast cancer cells leave the breast for other parts of the body, researchers say.

Read More »

New drug approvals hit 21-year high in 2017

U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light — more than double the previous year — while the figure also rose in the EU.

Read More »

Top 20 Life Science Startups to Watch in 2018

BioSpace present its NextGen Bio “Class of 2018,” a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.

Read More »

Drinking hot tea linked to lowered glaucoma risk

People who drink hot tea daily may be less likely than others to develop glaucoma symptoms, U.S. researchers say.

Read More »

Page 9 of 9« First...56789

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!

Subscribe

Ad Right Bottom